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The terminal maturation of B lymphocytes, which occurs in germinal centres of secondary lymphoid organs upon antigen recognition, is accompanied by two additional molecular processing of immunoglobulin genes that increase the efficiency of the humoral response: (1) the class switch recombination (CSR, Figure 2 ) exchanges the immunoglobulin (Ig) constant region (CH), thus modifying the function of the Ig without altering its antigenic specificity (Manis et al., 2002b) and (2) somatic hypermutations are introduced in the Ig variable domains, thus increasing their affinity for antigen (Papavasiliou and Schatz, 2002) . These two events are initiated by the B-cell-specific activationinduced cytidine deaminase (AID) (see Dudley et al. (2005) for a review on CSR). CSR involves large repetitive switch (S) region sequences located upstream of each C H gene, except C d . Mechanistically, breaks are introduced in the DNA of the two participating S regions, followed by their fusion, while the intervening sequence, including C m , is excised. CSR requires transcription through the target regions, and is initiated by AID (Muramatsu et al., 2000; Revy et al., 2000) . Similarly to the Rag1/2 situation, AID is a B-cell-specific factor needed to initiate CSR. Although AID shares sequence identity with the RNA-editing enzyme APO-BEC-1, it is now generally agreed that AID exerts its cytidine deamination function directly on singlestranded DNA; the processing of these deaminated residues resulting in the generation of DNA dsbs.
In summary, V(D)J recombination and CSR represent highly specific modifications of the genome that intervene by the targeted introduction of DNA breaks in lymphocytes at various stage of their development and maturation. As such, these molecular processes rely upon efficient DNA repair machineries. Indeed, several essential DNA repair factors were identified through the molecular analyses of immune deficiency conditions in men and mice over the last decade. Further insights into the role of these factors in cells of the immune system were recently gained through the design of new animal models of conditional gene inactivation. We discuss here the role of NHEJ 'core' factors in V(D)J recombination and CSR, and particularly their apparent different requirement during these two molecular processes.
V(D)J recombination deficiencies in humans: RS-SCIDs and SCID with microcephaly
Severe combined immune deficiencies (SCIDs) comprise about 11 inherited rare disorders which have in common a block of T-cell differentiation/function associated with a direct or indirect impairment of B-cell immunity (Fischer, 2004) . As a consequence of their molecular defects, the clinical presentation of SCID patients is rather uniform and mainly characterized by the early onset of infections affecting the respiratory tract and the gut. Common opportunistic organisms (Pneumocystis carinii and Aspergillus) as well as viruses (Cytomegalovirus for example) cause recurrent infections and failure to thrive. About 30% of human SCID cases arise from a defect in V(D)J recombination (Table 1) , leading to an early arrest of both B and T lymphocytes. This T-B-SCID condition can be either the result of deleterious mutations in the Rag1 and Rag2 genes (Villa et al., 2001) , affecting the initiation of the V(D)J recombination, or else impinge on the DNA repair phase of the V(D)J recombination reaction. In the latter case, the immune deficiency is accompanied by an increased cellular sensitivity to ionizing radiation (IR) (RS-SCIDs), a condition resembling the murine scid situation. In addition to these rather straightforward clinical presentations, several other immune deficiencies caused by variable defects in V(D)J recombination have been described more recently, which are associated with additional developmental anomalies such as a facial dysmorphy and microcephaly. The molecular analyses of these human and murine pathologies were highly instrumental in defining some of the actors of the NHEJ pathway.
The scid mouse and the CHO-XRCC mutants The description of the scid mouse (Bosma et al., 1983) , a natural mutant mouse characterized by a lack of circulating B and T lymphocytes, as resulting from a The V(D)J reaction can be divided into three steps. The Rag1/2 complex introduces a DNA dsb at the border between VH and DH segments and their respective recombination signal sequences (RSS), creating hairpin-sealed coding ends and blunt signal ends. Artemis, which is recruited and phosphorylated by the Ku/DNA-PK complex, opens the hairpins through its endonuclease activity. The XRCC4/ Cernunnos/DNA-LigaseIV complex finally seals coding and signal joins. NHEJ, non-homologous end-joining; IgH, immunoglobulin H general DNA repair defect accompanied by an increased sensitivity to IR or other agents causing DNA dsb, provided the initial link between V(D)J recombination and general DNA dsb repair (Fulop and Phillips, 1990; Biedermann et al., 1991; Hendrickson et al., 1991) . The faulty V(D)J recombination in scid mice can be demonstrated in pre-T and pre-B cells using extrachromosomal V(D)J recombination substrates (Lieber et al., 1988) as well as on endogenous T-cell receptor loci in ex vivo isolated thymocytes (Roth et al., 1992) . The design of V(D)J recombination substrates was at the base of the strategy for the identification of the Rag1 and Rag2 (Schatz et al., 1989; Oettinger et al., 1990) genes and are still in use in many laboratories to assess various aspects of V(D)J recombination. Another major breakthrough came from the very clever idea of performing V(D)J assays in mutagenized Chinese hamster ovary cells that had been initially selected for their DNA repair defect revealed by an increased X-ray sensitivity (XRCC mutants). Several of these mutants happened to be V(D)J recombination defective (Pergola et al., 1993; Taccioli et al., 1993) . To summarize years of intensive work in many laboratories, these experiments entitled the definition of two important protein complexes at play during NHEJ; the DNA-PK complex formed by Ku70 (XRCC6), Ku80 (XRCC5) and the DNA-PKcs catalytic subunit (XRCC7, Mu-scid) on one hand and the XRCC4/DNA-LigaseIV on the other hand. The precise function and activities of these NHEJ factors have been thoroughly reviewed in recent years (Weterings and van Gent, 2004) . Briefly, the DNA-PK complex identifies the Rag1/2-generated DNA-dsb and recruits the processing enzyme Artemis (see below), while the XRCC4/DNA-LigaseIV complex, together with Cernunnos (see below), terminates the reaction by rejoining the broken DNA ends.
Artemis
Some B-T-SCID patients do not harbour mutation in either Rag1 or Rag2 genes, yet they present the same clinical/biological features as Rag1/2-defective T-B-SCIDs, that is a complete absence of circulating mature B and T lymphocytes. The alymphocytosis in these patients is accompanied by an increased sensitivity to IRs of bone marrow cells (colony-forming units granulocyte-macrophage) and skin fibroblasts (Cavazzana-Calvo et al., 1993) . This characteristic, also shared by the scid mice, led to the hypothesis of a general DNA repair defect in RS-SCID patients. The RS-SCID phenotype is also found with high incidence among Athabascan-speaking Native American Indians. Consistent with their general DNA repair deficiency, they present a V(D)J recombination defect which can be demonstrated in vitro, in fibroblasts, using V(D)J recombination substrates and ectopic expression of both Figure 2 Immunoglobulin class switch recombination. Switch regions situated upstream of the constant regions of immunoglobulin (Sm, blue and Sg1, pink on this figure) are the target of AID that deaminates cytidine residues and thus generates uridine. The U/G mismatches are recognized by UNG, which removes the bases, and create abasic sites. The abasic sites are possibly cleaved by a specific endonuclease such as APE1 thus creating DNA nicks. DNA nicks generated on the two DNA strands lead to staggered DNA double-strand breaks. Nucleases and/or polymerases modify these DNA extremities to generate blunt ends that are joined by NHEJ process but also likely by other not yet well-characterized ways. CSR, class switch recombination; AID, activation-induced cytidine deaminase; UNG, uracil-N-glycosylase; APE1, apurinic/ apyrimidic endonuclease 1; NHEJ, non-homologous end-joining Abbreviation: NHEJ, non-homologous end-joining.
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Rag1 and Rag2 genes (Nicolas et al., 1998; Moshous et al., 2000) . Despite the strong similarity of RS-SCID patients and scid mice, DNA-PK activity is normal in these patients and the implication of the DNA-PKcs gene has been ruled out by genetic means in several families (Nicolas et al., 1996) . The disease-related locus in RS-SCID was assigned to the short arm of the chromosome 10 (Li et al., 1998; Moshous et al., 2000) . Given the location of the RS-SCID locus on human chromosome 10, genomic DNA sequences covering this region were analysed in silico for the presence of putative genes, leading to the identification of a new DNA repair factor called Artemis (Moshous et al., 2001a) . Functional complementation studies and mutation analyses certified that Artemis was indeed the gene defective in RS-SCID. Consistent with its function during V(D)J recombination and DNA repair, Artemis is ubiquitously expressed and is localized in the nucleus. Artemis mutations, which account for the RS-SCID condition, are primarily localized in the N-terminus half of the protein, thought to harbour the catalytic domain. These mutations involve non-sense and missense substitutions as well as splicing defects leading to severely truncated proteins. The inactivation of the Artemis gene in mice recapitulates the clinical and biological features of RS-SCID patients (Rooney et al., 2002; Li et al., 2005) . Hypomorphic Artemis mutations have been identified in patients presenting a leaky SCID phenotype (Ege et al., 2005; Gennery et al., 2005) as well as in one patient characterized by a progressive combined immune deficiency resulting from an elevated lymphocyte apoptosis but a delayed cell death of IR-treated fibroblasts in vitro (Evans et al., 2006) .
Artemis structure and function. In depth in silico Artemis sequence analysis highlighted significant similarities of the first 150 amino acids to well-established members of the metallo-b-lactamase superfamily (Moshous et al., 2001a) . The metallo-b-lactamase fold is adopted by various metallo-enzymes with a widespread distribution and substrate specificity (Aravind, 1999) . It consists of a four-layered sandwich with two mixed sheets flanked by a-helices. Biochemical studies demonstrated that Artemis does indeed exert an intrinsic 5 0 to 3 0 exonuclease activity in vitro (Ma et al., 2002) . A similar exonuclease activity has also been recognized in Apollo/SNM1B, a protein related to Artemis that functions in the protection of telomeres (Lenain et al., 2006; van Overbeek and de Lange, 2006) . When Artemis is associated with and phosphorylated by DNA-PKcs, it switches its catalytic activity to a DNA endonuclease capable of opening Rag1/ 2-generated hairpin structures during V(D)J recombination (Ma et al., 2002) . Consistent with this hairpin opening activity, Artemis and DNA-PKcs are required for efficient adeno-associated virus infection, the process of which goes through resolution of hairpin loops at the adenoassociated virus inverted terminal repeat (ITR) extremity of the viral DNA genome (Inagaki et al., 2007) . Sequence analysis, secondary structure prediction and mutagenesis studies clearly indicated the conservation of motifs (HxHxDH) typical of the metallo-b-lactamase fold, participating in the metal-binding pocket and representing the catalytic site of the metallo-b-lactamases (Callebaut et al., 2002; Pannicke et al., 2004; Poinsignon et al., 2004b; Niewolik et al., 2006) . Following the metallo-b-lactamase domain, Artemis shares several conserved features with other metallo-b-lactamases acting specifically on nucleic acids and involved in DNA repair (Artemis, SNM1, PSO2 ) and RNA processing (CPSF). This new domain was called b-CASP (Callebaut et al., 2002) . The b-CASP domain, which is always appended to a metallo-blactamase domain, is strictly required for Artemis function (Poinsignon et al., 2004b) . The three-dimensional structure of several RNA-specific b-CASP members has recently revealed the general organization of these proteins into two domains: a metallo-b-lactamase domain and a b-CASP domain, with the active site being located at the interface between the two domains (Ishikawa et al., 2006; Mandel et al., 2006) . Several Serine residues, mostly located in the C-terminus half of the protein, have been identified in vitro and in vivo as targets of phosphatidylinositol 3-kinase like kinases, including DNA-PKcs (Poinsignon et al., 2004a; Riballo et al., 2004; Zhang et al., 2004; Chen et al., 2005; Ma et al., 2005; Wang et al., 2005b; Goodarzi et al., 2006; Soubeyrand et al., 2006) . Unexpectedly however, Artemis function in V(D)J recombination does not rely upon the phosphorylation of these sites. Moreover, a truncated version of Artemis lacking the C-terminus half is still proficient in V(D)J recombination (Poinsignon et al., 2004a; Niewolik et al., 2006) . One current hypothesis is that, in the absence of DNA-PKcs, Artemis would adopt a particular conformation by which its C-terminus domain masks the b-Lact/b-CASP catalytic site. Artemis would then gain its full enzymatic activity through conformational changes upon DNA-PKcs interaction (Poinsignon et al., 2004b; Ma et al., 2005) . Another proposed function for DNA-PKcs would be to facilitate the access of Artemis to DNA damage. DNA-PKcs is indeed required for the proper loading of Artemis on damaged chromatin (Drouet et al., 2006) . However, although DNA-PK kinase activity prevents Artemis dissociation from the DNA-PK/DNA complex, it is the autophosphorylation of DNA-PKcs and not that of Artemis which is critical for the ultimate activation of Artemis endonuclease activity (Goodarzi et al., 2006) , which suggests that conformational changes triggered by DNA-PKcs autophosphorylation expose DNA ends for further processing by Artemis.
Artemis and the DNA damage response. RS-SCID patients and Artemis knockout (KO) mice present, in addition to their V(D)J recombination defect, a general increased cellular sensitivity to DNA-damaging agents, arguing for an Artemis function during the repair of these damages. Indeed, the repair of about 10% of DNA lesions inflicted by IRs rely on Artemis as shown by the retention of gH2AX foci, a marker of DNA breaks (Rogakou et al., 1998) , on a fraction of cells at late time points following IR (Riballo et al., 2004; Darroudi et al., 2007) . Artemis was found to process 3 0 -phosphoglycolate terminally blocked DSB in vitro, DNA modifications known to be induced by IR or bleomycin in vivo (Povirk et al., 2007) . Artemis thus appears to be one constituent of the DNA damage response (DDR). The DDR is orchestrated by a series of biochemical events among which protein phosphorylation by the phosphatidylinositol 3-kinase like kinases , ATM and ATR, play a central role (for a review, see Sancar et al., 2004) . Like many DNA repair factors, Artemis is hyperphosphorylated in an ATM-dependent manner after IR (Poinsignon et al., 2004a; Riballo et al., 2004; Zhang et al., 2004; Chen et al., 2005; Ma et al., 2005; Wang et al., 2005b; Goodarzi et al., 2006; Geng et al., 2007) . The exact role of ATM-dependent phosphorylation of Artemis during DNA repair is not fully understood as mutations of the phosphorylation sites do not impact on the capacity of these Artemis mutants to complement the radiosensitivity of Artemis-deficient fibroblasts (Poinsignon et al., 2004a) . In addition to the DNA repair per se, cell cycle checkpoints constitute another key feature of the DDR. Following DNA damage, the cells arrest their cycling at the G1/S and the G2/M boundaries to allow DNA repair to proceed. In the case of IR-induced DNA damage, these cell cycle checkpoints depend on ATM.
Whether Artemis participate in cell cycle checkpoints remained a matter of debate. Although it is clear that Artemis-deficient cells arrest normally in G1 following IR, the maintenance and/or recovery from the G2/M checkpoint following IR was found altered (Zhang et al., 2004; Wang et al., 2005b; Deckbar et al., 2007; Krempler et al., 2007) . Whether this reflects a direct function of Artemis on cell cycle through the regulation of Cdk1-cyclin B (Zhang et al., 2004) or the impaired repair of a subset of damage after IR Krempler et al., 2007) remains an open issue.
DNA-LigaseIV DNA-LigaseIV mutations were first identified in patients presenting developmental anomalies and immunodeficiency (O'Driscoll et al., 2001) . In contrast to RS-SCIDs, these patients are not completely devoid of B and T lymphocytes, although their numbers can be drastically reduced. Several other reports of DNA-LigaseIV deficiency further demonstrated the high heterogeneity of this syndrome for its impact on immunodeficiency (from no deficiency to SCID) as well as on its developmental consequences (with or without microcephaly) and cancer incidence (Ben-Omran et al., 2005; Enders et al., 2006; van der Burg et al., 2006; Buck et al., 2006b ). In the more severe forms, the V(D)J recombination is strongly affected both quantitatively and qualitatively as a consequence of the DNA rejoining deficiency. Whatever the nature of human DNA-LigaseIV mutations, they all result in partial loss of function alleles.
Cernunnos
Another series of five patients characterized by severe combined immunodeficiency associated with growth delay and microcephaly was reported (Buck et al., 2006a) . The clinical and cellular phenotypes of these patients (including increased radiosensitivity, defective V(D)J recombination, impaired in vitro NHEJ activity) was strikingly reminiscent to that observed in DNA-LigaseIV condition (see above). However, neither DNA-LigaseIV nor the other known NHEJ factors were found mutated, suggesting that these patients suffered from a novel NHEJ defect (Revy et al., 2005) . A new NHEJ factor, named Cernunnos, was indeed identified through cDNA functional complementation of patients' fibroblasts. The same NHEJ factor, named XLF (for XRCC4-like factor), was independently identified through a yeast two-hybrid screen using XRCC4 as bait . Recently developed murine Cernunnos-deficient ES cells present a phenotype similar to that of human deficient cells (increased radiosensitivity, genomic instability, DNA repair defect), except for V(D)J recombination (Zha et al., 2007) . Although the efficiency of V(D)J recombination is highly compromised, the fidelity of signal joins is not altered in Cernunnos-deficient ES cells, contrasting with the human situation where more than half of the signal joins are imprecise, with various lengths of nucleotide deletions (Dai et al., 2003; Buck et al., 2006a) . The nature of the mutation engineered in ES cells (the deletion of Cernunnos exons 4 and 5 could result in the low level expression of a truncated Cernunnos protein created by an in-frame splicing from exon 3 to exon 6) may partly account for these differences (Zha et al., 2007) .
Deleterious mutations of the Cernunnos gene were found in all patients and the ectopic expression of a wild-type Cernunnos complemented the DNA repair defect observed in patients'cells Buck et al., 2006a) . Whether these mutations lead to a complete loss of function or represent hypomorphic alleles is not yet known with certainty. Given the structural and functional relationships between Cernunnos/ XLF and XRCC4 (see below), one would expect a complete loss of function allele not to be compatible with life as is the case for XRCC4 KO mice. The development of a Cernunnos complete loss of function murine model will certainly help to address these issues.
Cernunnos structure. The human Cernunnos gene, composed of eight exons, is located on the long arm of chromosome 2 (2q35) and is expressed as a 2063 nucleotides long cDNA Buck et al., 2006a) . The Cernunnos/XLF protein is 299 aminoacid long with an apparent weight of about 33 kDa. Cernunnos is ubiquitously expressed and localized predominantly in the nucleus. Sequence analysis revealed that Cernunnos shares structural features with XRCC4 revealing the existence of a new protein family (Callebaut et al., 2002; Ahnesorg et al., 2006; Hentges et al., 2006) . Based on the XRCC4 structure (Junop et al., 2000; Sibanda et al., 2001) , one can predict a similar conformation for Cernunnos, that is a globular head domain followed by a coil-coiled tail Callebaut et al., 2006; Hentges et al., 2006) . Cernunnos/XLF, like XRCC4, can bind DNA in a sequence-independent manner (Hentges et al., 2006; Lu et al., 2007 Deshpande and Wilson, 2007) . Their globular head domains could drive their direct association. Both Cernunnos/XLF and XRCC4 appear to directly interact with DNA-LigaseIV but the Cernunnos/XLF-DNA-LigaseIV interaction is very weak (Hentges et al., 2006; Deshpande and Wilson, 2007) . The exact nature of the complex(es) formed between XRCC4, DNA-LigaseIV and Cernunnos/XLF remains to be clearly established, but one can anticipate that differential complex formation may have important regulatory function for the DNA-end ligation reaction during the NHEJ process.
Lastly, sequence analysis revealed that Cernunnos/XLF, although highly divergent, is the genuine orthologue of Nej1p/Lif2 (Callebaut et al., 2006 ), a NHEJ factor described in the yeast Saccharomyces cerevisiae (FrankVaillant and Marcand, 2001; Kegel et al., 2001; Valencia et al., 2001) . Cernunnos orthologues (referenced as Nej1p or XLF1) have further been found in many eukaryotes demonstrating that Nej1p and Cernunnos/XLF belong to the same protein family (Callebaut et al., 2006; Hentges et al., 2006; Cavero et al., 2007) . Nej1p in yeast interacts with the XRCC4 orthologue Lif1p, suggesting that Nej1p and Cernunnos/XLF have conserved an analogous function throughout evolution.
Cernunnos function. Like XRCC4 and several other factors that participate in the DDR, Cernunnos/XLF and its yeast orthologue Nej1p are phosphorylated upon DNA damage (Ahnesorg and Jackson, 2007; Wu et al., 2007) . However, the recruitment of Cernunnos to the site of DNA breaks does not require this DNA-PKdependent phosphorylation event (Wu et al., 2007) . Although XRCC4 and Cernunnos share structural characteristics and are part of the same complex, the overexpression of XRCC4 cannot functionally complement Cernunnos-deficient cells (Callebaut et al., 2006) , suggesting that these two factors participate to the DNA-end ligation activity in a cooperative manner. Moreover, the defects of XRCC4 or Cernunnos have different impact on the DNA-LigaseIV protein. Whereas DNA-LigaseIV protein is destabilized in the absence of XRCC4 (Grawunder et al., 1998; Teo and Jackson, 2000) , this is not the case in Cernunnos-deficient cells Callebaut et al., 2006) . Although the XRCC4/DNA-LigaseIV complex exerts DNA-end ligation in vitro , Cernunnos/ XLF further potentiates this activity (Hentges et al., 2006; Lu et al., 2007) . The presence of Cernunnos, which seems particularly important for the ligation of mismatched or noncohesive DNA ends but not of compatible DNA ends in vitro (Gu et al., 2007; Tsai et al., 2007) would suggest that it may potentiate the ligation activity of the XRCC4/DNA-LigIV complex on specific DNA end structures. Although the information concerning the role of Cernunnos are still scarce, the attractive hypothesis that XRCC4 stabilizes DNALigaseIV while Cernunnos switches-on the ligase activity of the XRCC4/DNA-LigaseIV complex can however be drawn. Hence, several corollaries follow this hypothesis:
(1) Cernunnos might be a crucial regulator of the NHEJ process (as is the case for its S. cerevisiae orthologue Nej1p, see below) and (2) The Cernunnos ability to interact with the DNA-LigIV/XRCC4 complex and/or to associate with the DNA breaks and/or to potentiate the ligase activity should be tightly regulated (either transcriptionally as is the case for Nej1p, or posttranscriptionally or both). These hypotheses will be certainly tested in the next future and the structural analysis of Cernunnos crystal alone or in association with XRCC4 and DNA-LigaseIV will also be of great interest to unravel the specific role of Cernunnos.
V(D)J recombination and CSR in NHEJ-deficient animal models

NHEJ KO mice
In addition to the scid mouse, deficient animal models were developed for the various NHEJ factors. All these models have in common an impact on V(D)J recombination and consequently on lymphocyte developmental arrest, thus recapitulating the human RS-SCID condition (Revy et al., 2005) . In the case of XRCC4 and DNA-LigaseIV KO mice, the immunological phenotype is accompanied by embryonic lethality owing to a massive apoptosis of post-mitotic neurons Gao et al., 1998) , the corollary of which in humans could be the microcephaly observed in DNALigaseIV and Cernunnos patients. Another very interesting aspect came out from the analyses of these models. When the NHEJ defect is crossed onto a P53 KO background, this invariably leads to the early onset of very aggressive Pro-B-cell lymphomas bearing chromosomal translocations, thus demonstrating that NHEJ factors are genetic caretakers (Franco et al., 2006) .
NHEJ and CSR
As eluded to in the introduction, experimental evidence has demonstrated that CSR, like V(D)J recombination, involves the generation of DNA dsb: (1) an episomal circle is generated during CSR (Chaudhuri and Alt, 2004) ; (2) AID-dependent DNA dsb have been detected by ligated mediated PCR assays in Switch regions of mitogen-activated B cells (Wuerffel et al., 1997; Catalan et al., 2003; Rush et al., 2004) ; (3) phosphorylation of histone H2AX (gH2AX), which spreads around DNA dsb, is detected at the IgH locus in an AID-dependent manner, in B cells activated for CSR (Petersen et al., 2001) ; (4) CSR is impaired in mice deficient for H2AX, ATM, p53 binding protein 1 and Nbs1, which are DDR early components (Reina-San-Martin et al., 2003 , 2004 Lumsden et al., 2004; Manis et al., 2004; Ward et al., 2004; Kracker et al., 2005) . The link between AIDdriven DNA cytidine deamination and the introduction of DNA dsb in Ig S regions is not fully established yet. AID deaminates cytidine residues transforming them to uracils, thus creating a U/G DNA mispair. The enzyme uracil-N-glycosylase (UNG), a key constituent of the base excision repair pathway, recognizes U/G mismatches and excises the uracil from DNA, thus creating an abasic site. As discussed below, the role of UNG in CSR has been substantiated by analysing UNG-deficient conditions in both human and mice (Rada et al., 2002; Imai et al., 2003) . An apurinic/apyrimidic endonuclease (likely APE1) then further processes this DNA modification by creating an ssDNA nick. Alternatively, the mismatch repair pathway could introduce DNA nicks directly at the U/G mispair. In both cases, two neighbouring nicks on the two DNA strands would then result in a staggered DNA dsb. The question arose as to which DNA repair pathway is instrumental for the resealing of these CSR DNA breaks, the NHEJ apparatus representing one obvious candidate.
The implication of NHEJ factors during CSR cannot be easily analysed in KO mice as they lack a mature immune system. A monoclonal mature B-cell compartment has been reconstituted by introducing rearranged IgH and IgL chain knock-in alleles (HL mice) in mice deficient for NHEJ factors. Ku70-and Ku80-deficient B cells have severely impaired CSR (Casellas et al., 1998; Manis et al., 1998; Reina-San-Martin et al., 2003) , but this defect could result from a reduced cellular proliferative capacity or increased apoptosis of B cells rather than a CSR defect per se (Manis et al., 1998; Reina-SanMartin et al., 2003) . Conflicting results were reported concerning the role of DNA-PKcs in CSR (Bosma et al., 2002; Manis et al., 2002a; Cook et al., 2003; Kiefer et al., 2007) . Finally, Artemis deficiency does not seem to have any impact on CSR in such monoclonal B-cell mice (Rooney et al., 2005) . Although some key NHEJ components seem to be required for CSR, one cannot exclude a role outside of NHEJ per se for these factors. XRCC4 and DNA-ligaseIV are the only factors without a known function apart from NHEJ, but the corresponding KO models are embryonic lethal, which does not facilitate the task of their study in CSR. To overcome this viability impact as well as the block in B-and T-cell maturation in XRCC4 KO mice, two laboratories recently developed XRCC4 and DNALigaseIV conditional gene targeting approaches through the use of LoxP/Cre technology (Soulas-Sprauel et al., 2007; Yan et al., 2007) . In these studies, the Cre expression is under the regulation of the B-cell-specific CD21 promoter, thus restraining the gene targeting in mature B cells. The analysis of CSR in these situations gave rather surprising results. In contrast to the V(D)J recombination process, which is completely abrogated in the absence of XRCC4 or DNA-LigaseIV in vitro and in vivo, mature B cells lacking either one of these two essential NHEJ factors retain the capacity, although reduced to about 50%, to undergo CSR as judged by the presence of all Ig isotypes in the serum of the respective mice. The reduced CSR activity, which is not attributable to any proliferative deficiency of the mature B cells, was further confirmed in vitro upon activation of purified B cells with the appropriate stimuli. This indicates that the classical XRCC4/DNA-LigaseIV NHEJ pathway, although certainly involved in CSR, coexists with or can be substituted by another molecular mechanism of DNA end-joining. An alternative (or Backup) DNA end-joining pathway has previously been identified in the absence of the classical (C) NHEJ apparatus (Audebert et al., 2004; Wang et al., 2005a Wang et al., , 2006 . This alternative pathway, which is also DNA-PK independent, relies on the base excision repair XRCC1/ DNA-LigaseIII complex in place of XRCC4/DNALigaseIV and also involves the Poly(ADP-ribose) polymerase-1 protein as a possible factor ensuring the synapsis of DNA ends. This alternative pathway is thought to operate through the recognition/usage of microhomologies at the DNA break borders, the signature of which is imprinted at the resulting DNA junction (Roth et al., 1985) . Another type of alternative end-joining pathway, which can operate in the absence of bona fide NHEJ and relies on microhomology (microhomology mediated end joining (MMEJ) pathway) has been known for quite a while in yeast (Boulton and Jackson, 1996) . This pathway, whose efficiency is directly linked to the available length of homology, borrows factors from the homologous recombination, the mismatch repair and the base excision repair machineries and is strongly inhibited by the NHEJ factor Ku70 in fission yeast (Decottignies, 2007) . Interestingly, sequencing CSR junctions in XRCC4-deficient B cells revealed a slight increase in microhomology usage, further supporting the implication of alternative end-joining during CSR in C-NHEJ-deficient B cells. These observations agree with those obtained on B cells from human patients with hypomorphic DNAligaseIV mutations which also display an altered pattern of CSR junctional resolution, with increased microhomology in Sm-Sa junctions (Pan-Hammarstrom et al., 2005) . Whether the XRCC1/DNA-LigaseIII end-joining pathway, the MMEJ, or a combination of both indeed account for the completion of CSR in XRCC4/DNALigaseIV-deficient B cells, and maybe to a certain extent in normal B cells, now requires more direct investigations. It is maybe not too surprising that a DNA endjoining mechanism similar to that of single strand annealing can operate during CSR for at least two reasons: (1) the DNA dsb generated during CSR most certainly harbour single-stranded extremities as it is the result of two neighbouring single-strand breaks generated during the repair of AID-generated base mispairing and (2) the various S regions in which the DNA dsb occur have a certain degree of homology among each other (Sm and Sa being the most homologous), thus favouring short homology pairing.
Conclusions: how to regulate various DNA repair pathways?
Two major DNA repair pathways in eukaryotes account for the repair of DNA breaks: homologous recombination (HR) and NHEJ (reviewed in Sancar et al., 2004) . HR is precise and replaces the damaged region by copying on the homologous chromatid, whereas NHEJ is error prone as it does not rely on the intact DNA copy. While it is generally accepted that HR is, by essence, mostly used during late S and G2 phases of the cell cycle when sister chromatids are available and NHEJ is mostly restricted to cells in G1, a large overlap does indeed exist, if not between these two major pathways, at least among some of their constituents. In addition, several other alternative routes may intervene in the repair of DNA breaks as discussed in the previous section. This situation raises the question of the regulation of these various pathways (Sonoda et al., 2006; Wyman and Kanaar, 2006) . Is there indeed an active regulation of DNA repair pathways? How does it operate? What are the consequences of a default of this regulation?
Lower eukaryotes such as S. cerevisiae rely mostly on HR for the repair of DNA breaks and indeed only on an HR-deficient genetic background is it possible to clearly observe NHEJ-mediated DNA repair (Schar et al., 1997; Teo and Jackson, 1997; Wilson et al., 1997) . Diploid MATa/MATa yeasts demonstrate lower NHEJ activity than their haploid MATa and MATa counterparts. This regulation of NHEJ in diploids is correlated with the specific downregulated expression of Nej1p/Lif2p in these cells as compared to haploids (Frank-Vaillant and Marcand, 2001; Kegel et al., 2001; Ooi et al., 2001; Valencia et al., 2001) . The ectopic expression of Nej1p/ Lif2p restores NHEJ to some extent. Nej1p/Lif2p has thus been considered as an NHEJ regulator in yeast. Interestingly, Nej1p/Lif2p is the yeast orthologue of Cernunnos and as such is critically required during NHEJ. Whether Cernunnos has a comparable regulatory role in higher eukaryotes certainly represents an interesting issue to pursue.
The two recombination processes in the immune system (V(D)J recombination and CSR) may represent new paradigms to study these regulation issues ( Figure 3 and Table 2 ). Both processes generate DNA dsbs which trigger the general DDR machinery as shown by the presence of gH2AX and other constituents of the socalled DNA repair foci at rearranging T-cell receptor and B-cell receptor loci or at IgH loci in B cells undergoing CSR (reviewed in Jankovic et al., 2007) . However, while the DDR factors (ATM, H2AX, p53 binding protein 1, Nbs1) are dispensable for the completion of V(D)J recombination, they are required for CSR. Bassing and Alt (2004) have proposed that Figure 3 Classical and alternative NHEJ in the immune system. NHEJ, non-homologous end-joining; CSR, class switch recombination; HR, homologous recombination; 53BP1, p53-binding protein 1. NHEJ in the immune system P Soulas-Sprauel et al during CSR, the DDR factors, and in particular the core component of chromatin H2AX, may be instrumental in maintaining the DNA broken ends in close proximity during DNA repair. During V(D)J recombination, this synapsis function is ensured by the Rag1 and Rag2 proteins themselves, which are known to remain on broken ends as a post-cleavage complex (reviewed in Ooi et al., 2001) . The Rag1/2 synaptic complex would then represent a scaffold that facilitates the recruitment (or 'choice') of which DNA repair machinery will reseal the breaks. Particular mutations in Rag1, which destabilize the post-cleavage complex, in fact impair the DNA end-joining phase, thus strongly diminishing the efficiency of the V(D)J reaction (Roth, 2003) . Most interestingly, some of these mutations also allow for HR and alternative NHEJ to operate on the DNA breaks to some extent (Lee et al., 2004) . Based on this observation, Lee et al. proposed that one important function of the Rag1/2 post-cleavage complex is to 'shepherd' the Rag1/ 2-generated DNA dsb towards the classical NHEJ pathway, excluding the use of either HR or any other alternative NHEJ machinery. This was further reinforced by showing that when V(D)J recombination is driven by a particular Rag2 mutant, it can even occur in NHEJ-deficient cells (Corneo et al., 2007) . Perhaps most importantly, this last study demonstrates that alternative NHEJ is quite robust and can even participate in DNA end-joining in NHEJ-proficient cells, which further raises the question of regulation among the various DNA repair pathways. In the case of CSR, the synapsis of DNA ends being probably maintained by the DDR complex (Ooi et al., 2001) , this complex also recruits the DNA end-joining machinery and one can assume that NHEJ is preferred over other pathways but can easily be replaced in case of faulty NHEJ, as shown with XRCC4 conditional KO mice (Soulas-Sprauel et al., 2007; Yan et al., 2007) , given the homology that exists between S regions. The DNA repair phase of CSR is not presently fully understood and other factors have yet to be identified (Peron et al., 2007) . Whether NHEJ will be exclusively used in physiological CSR condition has to be addressed further. The issue of DNA repair pathway regulation is a central question and several animal models have demonstrated that usage of the inappropriate pathway during both V(D)J recombination and CSR can lead to chromosomal translocations and the subsequent development of immune malignancies (reviewed in Jankovic et al., 2007) .
